Table 3.
Comorbidities of NMOSD during 2016–2018.
| Comorbidities, No. (%) | 2016 (n=4580) |
2017 (n=5768) |
2018 (n=7068) |
|||
|---|---|---|---|---|---|---|
| Child (n=262) | Adult (n=4318) | Child (n=344) | Adult (n=5424) | Child (n=413) | Adult (n=6655) | |
| Hypertension | 4 (1•5) | 572 (13•2) | 1 (0•3) | 750 (13•8) | 1 (0•2) | 991 (14•9) |
| Diabetes | 1 (0•4) | 274 (6•3) | 2 (0•6) | 374 (6•9) | 3 (0•7) | 515 (7•7) |
| Hyperlipidemia | 3 (1•1) | 551 (12•8) | 3 (0•9) | 752 (13•9) | 4 (1) | 891 (13•4) |
| Osteoporosis | 0 (0) | 146 (3•4) | 0 (0) | 204 (3•8) | 0 (0) | 258 (3•9) |
| Stroke | 1 (0•4) | 283 (6•6) | 0 (0) | 401 (7•4) | 1 (0•2) | 517 (7•8) |
| Malignant tumor | 0 (0) | 37 (0•9) | 0 (0) | 66 (1•2) | 1 (0•2) | 79 (1•2) |
| Depression/anxiety | 2 (0•8) | 171 (4) | 4 (1•2) | 220 (4•1) | 4 (1) | 331 (5) |
| Autoimmune diseases | 15 (5•7) | 379 (8•8) | 11 (3•2) | 586 (10•8) | 18 (4•4) | 741 (11•1) |
| Bechet's disease | 0 (0) | 7 (0•2) | 0 (0) | 2 (0) | 0 (0) | 4 (0•1) |
| Sjögren's syndrome | 5 (1•9) | 261 (6) | 4 (1•2) | 372 (6•9) | 5 (1•2) | 477 (7•2) |
| SLE | 8 (3•1) | 78 (1•8) | 5 (1•5) | 137 (2•5) | 11 (2•7) | 148 (2•2) |
| Arthritis | 0 (0) | 1 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (0) |
| Other | 2 (0•8) | 32 (0•7) | 2 (0•6) | 75 (1•4) | 2 (0•5) | 111 (1•7) |
SLE: Systemic lupus erythematosus.